Literature DB >> 23558924

Forearm blood flow response to acute exercise in obese and non-obese males.

R Lee Franco1, B A Fallow, C J Huang, E O Acevedo, J A Arrowood, R K Evans.   

Abstract

Chronic exercise is thought to improve endothelium-dependent vasodilation; however, few studies have evaluated the effects of acute exercise on microvascular vasodilatory capacity (MVC). Moreover, no studies have compared MVC responses in obese and non-obese individuals following acute exercise. To evaluate MVC, utilizing forearm blood flow (FBF) and excess blood flow (EBF) before and up to 48 h after a single exercise bout to elicit peak oxygen consumption (VO2 peak) in obese and non-obese males. Twelve obese (37.0 ± 1.1 kg/m(2)) and 12 non-obese (21.9 ± 0.3 kg/m(2)) males volunteered to participate. FBF measures, before and during reactive hyperemia (RH), were obtained prior to (PRE-E), immediately after (POST-E), and at 1 (POST-1), 2 (POST-2), 24 (POST-24), and 48 (POST-48) hours after exercise. EBF, was calculated as the difference between FBF, before and during RH. Blood samples were obtained to evaluate the response of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α), which are potential modifiers of MVC. FBF before and during RH were significantly (P < 0.05) increased in both groups POST-E. The EBF magnitude of change from PRE-E was significantly (P < 0.05) elevated in non-obese when compared with obese males. Although not related to MVC, concentrations of IL-6 significantly decreased between POST-2 and POST-24 in both groups. An acute bout of exercise designed to elicit VO2 peak significantly increased forearm MVC in non-obese and obese males, although the magnitude of change in EBF from PRE-E to POST-E was greater in non-obese males.

Entities:  

Mesh:

Year:  2013        PMID: 23558924     DOI: 10.1007/s00421-013-2626-7

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  33 in total

1.  Interleukin-6 and tumor necrosis factor-alpha levels increase in response to maximal exercise in patients with chronic heart failure.

Authors:  Toru Kinugawa; Masahiko Kato; Kazuhide Ogino; Shuichi Osaki; Yoko Tomikura; Osamu Igawa; Ichiro Hisatome; Chiaki Shigemasa
Journal:  Int J Cardiol       Date:  2003-01       Impact factor: 4.164

Review 2.  Adipose tissue, inflammation and endothelial dysfunction.

Authors:  Jerzy Chudek; Andrzej Wiecek
Journal:  Pharmacol Rep       Date:  2006       Impact factor: 3.024

3.  Treatment options for obesity and potential therapies on the horizon.

Authors:  Carol A Motycka; Erin St Onge; Shannon A Miller
Journal:  P T       Date:  2011-05

4.  Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide.

Authors:  Y Higashi; S Sasaki; S Kurisu; A Yoshimizu; N Sasaki; H Matsuura; G Kajiyama; T Oshima
Journal:  Circulation       Date:  1999-09-14       Impact factor: 29.690

5.  Exercise-induced improvement in endothelial dysfunction is not mediated by changes in CV risk factors: pooled analysis of diverse patient populations.

Authors:  Daniel J Green; Jennifer H Walsh; Andrew Maiorana; Matthew J Best; Roger R Taylor; J Gerard O'Driscoll
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08-21       Impact factor: 4.733

6.  Both aerobic endurance and strength training programmes improve cardiovascular health in obese adults.

Authors:  Inga E Schjerve; Gjertrud A Tyldum; Arnt E Tjønna; Tomas Stølen; Jan P Loennechen; Harald E M Hansen; Per M Haram; Garreth Heinrich; Anja Bye; Sonia M Najjar; Godfrey L Smith; Stig A Slørdahl; Ole J Kemi; Ulrik Wisløff
Journal:  Clin Sci (Lond)       Date:  2008-11       Impact factor: 6.124

7.  Effects of diet and exercise on obesity-related vascular dysfunction in children.

Authors:  Kam S Woo; Ping Chook; Chung W Yu; Rita Y T Sung; Mu Qiao; Sophie S F Leung; Christopher W K Lam; Con Metreweli; David S Celermajer
Journal:  Circulation       Date:  2004-04-05       Impact factor: 29.690

Review 8.  Obesity and cardiovascular disease.

Authors:  Antonio Pérez Pérez; Juan Ybarra Muñoz; Vicente Blay Cortés; Pedro de Pablos Velasco
Journal:  Public Health Nutr       Date:  2007-10       Impact factor: 4.022

Review 9.  Physiological roles of muscle-derived interleukin-6 in response to exercise.

Authors:  Bente K Pedersen; Christian P Fischer
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2007-05       Impact factor: 4.294

Review 10.  The role of insulin and the adipocytokines in regulation of vascular endothelial function.

Authors:  Stuart A Ritchie; Marie-Ann Ewart; Colin G Perry; John M C Connell; Ian P Salt
Journal:  Clin Sci (Lond)       Date:  2004-12       Impact factor: 6.124

View more
  5 in total

1.  Role of obesity on cerebral hemodynamics and cardiorespiratory responses in healthy men during repetitive incremental lifting.

Authors:  Lora A Cavuoto; Rammohan V Maikala
Journal:  Eur J Appl Physiol       Date:  2015-04-21       Impact factor: 3.078

Review 2.  Obesity, kidney dysfunction and hypertension: mechanistic links.

Authors:  John E Hall; Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Michael E Hall
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

Review 3.  Emerging Roles of Sympathetic Nerves and Inflammation in Perivascular Adipose Tissue.

Authors:  Sophie N Saxton; Sarah B Withers; Anthony M Heagerty
Journal:  Cardiovasc Drugs Ther       Date:  2019-04       Impact factor: 3.727

4.  Obesity and the Role of Short Duration Submaximal Work on Cardiovascular and Cerebral Hemodynamics.

Authors:  Lora A Cavuoto; Rammohan V Maikala
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

5.  The acute and chronic effects of high-intensity exercise in hypoxia on blood pressure and post-exercise hypotension: A randomized cross-over trial.

Authors:  Geert Kleinnibbelink; Niels A Stens; Alessandro Fornasiero; Guilherme F Speretta; Arie P J Van Dijk; David A Low; David L Oxborough; Dick H J Thijssen
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.